Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Vasc Interv Radiol ; 2024 Oct 28.
Artigo em Inglês | MEDLINE | ID: mdl-39477084

RESUMO

OBJECTIVE: To assess the efficacy and safety of drug-eluting embolic bronchial arterial chemoembolization (DEE-BACE) in lung cancer, and to compare its outcomes with those of conventional bronchial arterial chemoembolization (cBACE). MATERIALS AND METHODS: A comprehensive search was conducted across PubMed, Embase, Cochrane Library, Web of Science, CNKI, VIP, and Wanfang databases. Random-effects model analysis was applied when I2 was ≥ 50%; otherwise, fixed-effects model analysis was used. Subgroup analysis was performed for I2 values ≥ 50%. Eighteen studies involving 681 patients were included, with 501 patients receiving DEE-BACE and 110 patients undergoing cBACE. RESULTS: Among lung cancer patients treated with DEE-BACE, the pooled objective response rates (ORRs) at 1, and 6 months were 64.4%, and 50.3%, respectively; the disease control rates (DCRs) were 93.4%, 74.4%, and 71.7%, respectively. The 1-year overall survival (OS) and progression-free survival (PFS) rate were 48.2%, and 22.5%, respectively. The incidence of adverse events was less than 50%. Compared with the cBACE group, the DEE-BACE group exhibited higher 1-month DCR [pooled relative risk (RR): 1.236, 95% confidence interval (CI): 1.028, 1.486), 6-month (pooled RR: 2.036, 95%CI: 1.226, 3.383) ORR and DCR (pooled RR: 1.824, 95%CI 1.249, 2.662). Both DEE-BACE and cBACE exhibited similar rates of adverse events. CONCLUSION: DEE-BACE presents a favorable efficacy and safety profile for lung cancer treatment compared with cBACE, particularly for nonresectable cases or when chemotherapy or radiation therapy options are limited. However, the lack of direct comparisons to standard treatments require cautious interpretation of these results.

2.
Sci Rep ; 14(1): 10741, 2024 05 10.
Artigo em Inglês | MEDLINE | ID: mdl-38730036

RESUMO

The majority of pigeon paramyxovirus type 1 (PPMV-1) strains are generally non-pathogenic to chickens; however, they can induce severe illness and high mortality rates in pigeons, leading to substantial economic repercussions. The genomes of 11 PPMV-1 isolates from deceased pigeons on meat pigeon farms during passive monitoring from 2009 to 2012 were sequenced and analyzed using polymerase chain reaction and phylogenetic analysis. The complete genome lengths of 11 isolates were approximately 15,192 nucleotides, displaying a consistent gene order of 3'-NP-P-M-F-HN-L-5'. ALL isolates exhibited the characteristic motif of 112RRQKRF117 at the fusion protein cleavage site, which is characteristic of velogenic Newcastle disease virus. Moreover, multiple mutations have been identified within the functional domains of the F and HN proteins, encompassing the fusion peptide, heptad repeat region, transmembrane domains, and neutralizing epitopes. Phylogenetic analysis based on sequences of the F gene unveiled that all isolates clustered within genotype VI in class II. Further classification identified at least two distinct sub-genotypes, with seven isolates classified as sub-genotype VI.2.1.1.2.2, whereas the others were classified as sub-genotype VI.2.1.1.2.1. This study suggests that both sub-genotypes were implicated in severe disease manifestation among meat pigeons, with sub-genotype VI.2.1.1.2.2 displaying an increasing prevalence among Shanghai's meat pigeon population since 2011. These results emphasize the value of developing pigeon-specific vaccines and molecular diagnostic tools for monitoring and proactively managing potential PPMV-1 outbreaks.


Assuntos
Columbidae , Genoma Viral , Doença de Newcastle , Vírus da Doença de Newcastle , Filogenia , Animais , Columbidae/virologia , China/epidemiologia , Vírus da Doença de Newcastle/genética , Vírus da Doença de Newcastle/isolamento & purificação , Vírus da Doença de Newcastle/classificação , Doença de Newcastle/virologia , Doença de Newcastle/epidemiologia , Genótipo , Fazendas , Carne/virologia
3.
Heliyon ; 9(4): e15240, 2023 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-37089316

RESUMO

The formation of left gastric artery aneurysms (LGAAs) is a very rare complication of microscopic polyangiitis (MPA). Hemorrhage due to ruptured LGAAs is life threatening. In this case report, an 81-year-old female patient diagnosed with MPA developed massive bleeding from a ruptured LGAA and hemorrhagic shock during hospitalization. The patient underwent endovascular therapy to successfully embolize the aneurysm with microcoils and recovered postoperatively.

4.
Medicine (Baltimore) ; 98(49): e18162, 2019 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-31804329

RESUMO

RATIONALE: The prognosis of lung cancer is dismal, which has resulted in lung carcinoma being one of the leading causes of cancer-related deaths worldwide. Non-small cell lung cancer accounts for approximately 80% of all types of lung carcinoma. The skeletal system and central nervous system are the most common distal metastatic sites in patients with lung cancer, while cutaneous and soft tissues metastasis is rare. PATIENT CONCERNS: We report a case of concomitant metastasis in the nasal tip and suspected buttocks metastasis secondary to lung cancer, who complained of repeated cough and white sputum for 6 months. DIAGNOSE: Primary lung cancer was diagnosed by bronchoscopy and biopsy, lesion on nasal tip was confirmed by biopsy. Furthermore, PET-CT scan identified the untouchable buttocks lesion that could have been easily missed. INTERVENTIONS: This patient refused systemic treatments, but he chose traditional Chinese medicine at home. OUTCOMES: He died 6 months after the diagnosis. LESSONS: The possibility of metastasis of primary cancers should be considered when encountering soft-tissue neoplasm lesions, and a biopsy of the suspicious cutaneous lesions could likely aid in the histological identification of the primary cancer. PET-CT scan could be an effective supplementary tool for the diagnosis and evaluation of cancers.


Assuntos
Neoplasias Pulmonares/patologia , Neoplasias Cutâneas/secundário , Neoplasias de Tecidos Moles/secundário , Humanos , Neoplasias Pulmonares/diagnóstico por imagem , Masculino , Pessoa de Meia-Idade , Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA